Branch of Shemyakin-Ovchinnikov Institute of Bioorganic Сhemistry, Russian Academy of Sciences, Science Avenue 6, Pushchino, Moscow Region 142290, Russia.
Kursk State Medical University, K. Marksa St 3, Kursk 305041, Russia.
J Immunol Res. 2017;2017:3940743. doi: 10.1155/2017/3940743. Epub 2017 Jun 11.
Previously transgenic plants producing an antimicrobial peptide cecropin P1 (CecP1) have been reported. Now we report biological testing extracts containing CecP1 as a candidate drug for treatment of wounds infected with The drug constitutes the whole juice from leaves (not ethanol extract) sterilized with nanofiltration. A microbicide activity of CecP1 against an animal fungal pathogen in vivo was demonstrated for the first time. However, a favorable therapeutic effect of the transgenic extract was attributed to a synergism between the fungicide activity of CecP1 and wound healing (antiscar), revascularizing, and immunomodulating effect of natural biologically active components of . A commercial fungicide preparation clotrimazole eliminated cells within infected wounds in rats with efficiency comparable to CecP1-enriched extract. But in contrast to extract, clotrimazole did not exhibit neither wound healing activity nor remodeling of the scar matrix. Taken together, our results allow assumption that CecP1-enriched extracts should be considered as a candidate drug for treatment of dermatomycoses, wounds infected with fungi, and bedsores.
先前已经有报道称,一些转基因植物能够产生一种抗菌肽 Cecropin P1(CecP1)。现在,我们报告了含有 CecP1 的提取物的生物测试结果,该提取物可作为治疗真菌感染伤口的候选药物。这种药物由经过纳米过滤除菌的叶片全汁组成(而非乙醇提取物)。这是首次证明 CecP1 对动物真菌病原体具有体内杀菌活性。然而,这种转基因植物提取物的良好治疗效果归因于 CecP1 的杀菌活性与伤口愈合(抗瘢痕)、新生血管化和天然生物活性成分的免疫调节作用之间的协同作用。一种市售的杀真菌剂克霉唑在治疗大鼠真菌感染伤口时的效率与 CecP1 富集的提取物相当,能够有效消除感染部位的细胞。但与 CecP1 富集的提取物不同,克霉唑既没有表现出伤口愈合活性,也没有对瘢痕基质进行重塑。总之,我们的研究结果表明, CecP1 富集的提取物应被视为治疗皮肤真菌病、真菌感染性伤口和褥疮的候选药物。